rs41281013

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001084.5(PLOD3):​c.1144G>C​(p.Asp382His) variant causes a missense change. The variant allele was found at a frequency of 0.00725 in 1,605,936 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. D382D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0057 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0074 ( 60 hom. )

Consequence

PLOD3
NM_001084.5 missense

Scores

3
5
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.94

Publications

8 publications found
Variant links:
Genes affected
PLOD3 (HGNC:9083): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 3) The protein encoded by this gene is a membrane-bound homodimeric enzyme that is localized to the cisternae of the rough endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VIB have deficiencies in lysyl hydroxylase activity. [provided by RefSeq, Jul 2008]
PLOD3 Gene-Disease associations (from GenCC):
  • bone fragility with contractures, arterial rupture, and deafness
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016706944).
BP6
Variant 7-101211934-C-G is Benign according to our data. Variant chr7-101211934-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 440182.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00571 (869/152258) while in subpopulation NFE AF = 0.0096 (653/68010). AF 95% confidence interval is 0.00899. There are 7 homozygotes in GnomAd4. There are 390 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLOD3NM_001084.5 linkc.1144G>C p.Asp382His missense_variant Exon 11 of 19 ENST00000223127.8 NP_001075.1 O60568Q9UG85

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLOD3ENST00000223127.8 linkc.1144G>C p.Asp382His missense_variant Exon 11 of 19 1 NM_001084.5 ENSP00000223127.3 O60568

Frequencies

GnomAD3 genomes
AF:
0.00570
AC:
867
AN:
152140
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00152
Gnomad AMI
AF:
0.0297
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.0121
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00960
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00586
AC:
1370
AN:
233818
AF XY:
0.00604
show subpopulations
Gnomad AFR exome
AF:
0.00137
Gnomad AMR exome
AF:
0.00260
Gnomad ASJ exome
AF:
0.0155
Gnomad EAS exome
AF:
0.0000573
Gnomad FIN exome
AF:
0.00192
Gnomad NFE exome
AF:
0.00934
Gnomad OTH exome
AF:
0.00815
GnomAD4 exome
AF:
0.00741
AC:
10767
AN:
1453678
Hom.:
60
Cov.:
31
AF XY:
0.00737
AC XY:
5323
AN XY:
722540
show subpopulations
African (AFR)
AF:
0.00132
AC:
44
AN:
33352
American (AMR)
AF:
0.00278
AC:
121
AN:
43478
Ashkenazi Jewish (ASJ)
AF:
0.0149
AC:
386
AN:
25936
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39392
South Asian (SAS)
AF:
0.00158
AC:
134
AN:
84982
European-Finnish (FIN)
AF:
0.00235
AC:
123
AN:
52442
Middle Eastern (MID)
AF:
0.0143
AC:
79
AN:
5506
European-Non Finnish (NFE)
AF:
0.00849
AC:
9413
AN:
1108578
Other (OTH)
AF:
0.00778
AC:
467
AN:
60012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
519
1038
1557
2076
2595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
324
648
972
1296
1620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00571
AC:
869
AN:
152258
Hom.:
7
Cov.:
32
AF XY:
0.00524
AC XY:
390
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.00154
AC:
64
AN:
41558
American (AMR)
AF:
0.00307
AC:
47
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0121
AC:
42
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4826
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10622
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00960
AC:
653
AN:
68010
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00899
Hom.:
3
Bravo
AF:
0.00578
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00830
AC:
32
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00919
AC:
79
ExAC
AF:
0.00582
AC:
706
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Sep 18, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PLOD3: BP4, BS2 -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Bone fragility with contractures, arterial rupture, and deafness Benign:2
Sep 25, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 07, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.26
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.040
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.67
D
Eigen
Benign
0.17
Eigen_PC
Benign
0.14
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D
MetaRNN
Benign
0.017
T
MetaSVM
Benign
-0.54
T
MutationAssessor
Uncertain
2.6
M
PhyloP100
4.9
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Pathogenic
0.65
Sift
Benign
0.098
T
Sift4G
Benign
0.11
T
Polyphen
0.95
P
Vest4
0.74
MVP
0.93
MPC
0.16
ClinPred
0.060
T
GERP RS
3.4
PromoterAI
0.0092
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.33
gMVP
0.74
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41281013; hg19: chr7-100855215; API